(Q39795331)

reason for preferred rank

14 September 2017

Pancreatic islet cell carcinoma with hypercalcemia and hypergastrinemia.Response to streptozotocin (English)

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

12 December 2022

Pancreatic islet cell carcinoma with hypercalcemia and hypergastrinemia: response to streptozotocin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A137070

12 December 2022

1 reference

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

12 December 2022

author name string

Hill GJ II

2

1 reference

14 September 2017

P. E. Cryer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A137070

12 December 2022

I. I. Hill GJ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A137070

12 December 2022

language of work or name

English

0 references

publication date

1 December 1976

1 reference

full work available at URL

14 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

12 December 2022

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

12 December 2022

1 reference

14 September 2017

38

1 reference

14 September 2017

2217-2221

1 reference

14 September 2017

6

1 reference

Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197612%2938%3A6%3C2217%3A%3AAID-CNCR2820380604%3E3.0.CO%3B2-G

Calcium and secretin-stimulated gastrin release in the Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197612%2938%3A6%3C2217%3A%3AAID-CNCR2820380604%3E3.0.CO%3B2-G

Secretion and metabolic efficacy of parthyroid hormone in patients with severe hypomagnesemia

21 January 2018

3

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Fasting hypoglycemia, hypercalcemia and hyperprolactinemia. Multiple endocrine neoplasia, type 1?

12 December 2022

4

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Hyperparathyroidism: gastric acid secretion and gastrin.

12 December 2022

5

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Effects of streptozotocin on an islet cell carcinoma with hypercalcemia

12 December 2022

6

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES

12 December 2022

7

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Radioimmunoassay Measurement of Prostaglandins E, A, and F in Human Plasma

12 December 2022

9

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Clinical and genetic investigation of a large kindred with multiple endocrine adenomatosis

12 December 2022

10

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Letter: Hypercalcemia and streptozotocin. In comment

12 December 2022

13

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma

12 December 2022

14

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin

12 December 2022

15

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Further studies on streptozotocin therapy for a multiple-hormone-producing islet cell carcinoma

12 December 2022

16

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Letter: Streptozotocin in the Zollinger-Ellison syndrome

12 December 2022

17

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Islet cell tumors: current concepts and management

12 December 2022

18

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Relationship of multiple endocrine adenomas to the syndrome of ulcerogenic islet cell adenomas (Zollinger-Ellison). Occurrence of both syndromes in one family.

12 December 2022

19

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Effects of calcium on serum gastrin levels in the zollinger-Ellison syndrome.

12 December 2022

20

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

Hyperparathyroidism in the Zollinger-Ellison syndrome. Influence of hypercalcemia on clinical course

12 December 2022

21

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN

12 December 2022

22

1 reference

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197612)38:6%3C2217::AID-CNCR2820380604%3E3.0.CO;2-G

12 December 2022

Identifiers

10.1002/1097-0142(197612)38:6<2217::AID-CNCR2820380604>3.0.CO;2-G

1 reference

14 September 2017

1 reference